Advisors Asset Management, Inc. Pfizer Inc Transaction History

Advisors Asset Management, Inc.

$4.99 Billion
Q2 2024

A detailed history of Advisors Asset Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 660,481 shares of PFE stock, worth $19.2 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

660,481

Previous 655,937 0.69%

Holding current value

$19.2 Million

Previous $18.2 Million 1.53%

% of portfolio

0.37%

Previous 0.36%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $114,781 - $134,502	4,544 Added 0.69%	660,481 $18.5 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $2.03 Million - $2.33 Million	78,352 Added 13.57%	655,937 $18.2 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $745,096 - $967,799	28,515 Added 5.19%	577,585 $16.6 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $921,854 - $1.07 Million	25,522 Added 4.87%	549,070 $20.1 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $418,439 - $544,747	-10,623 Reduced 1.99%	523,548 $21.4 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $698,185 - $911,403	16,723 Added 3.23%	534,171 $27.4 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $947,316 - $1.16 Million	-21,648 Reduced 4.02%	517,448 $22.6 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $1.26 Million - $1.49 Million	-27,082 Reduced 4.78%	539,096 $28.3 Million
Q1 2022 May 17, 2022	BUY	$45.75 - $56.69 $241,971 - $299,833	5,289 Added 0.94%	566,178 $29.3 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $836,234 - $1.24 Million	-20,238 Reduced 3.48%	560,889 $33.1 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $3.47 Million - $4.46 Million	-88,404 Reduced 13.2%	581,127 $25 Million
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $5.46 Million - $6.18 Million	-151,995 Reduced 18.5%	669,531 $26.2 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $3.49 Million - $3.94 Million	-104,357 Reduced 11.27%	821,526 $29.8 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $6.06 Million - $7.7 Million	-181,022 Reduced 16.35%	925,883 $34.1 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $1.96 Million - $2.3 Million	-61,636 Reduced 5.27%	1,106,905 $40.6 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $674,868 - $818,715	22,406 Added 1.95%	1,168,541 $38.2 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $2.46 Million - $3.51 Million	90,972 Added 8.62%	1,146,135 $37.4 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $185,175 - $210,150	5,625 Added 0.54%	1,055,163 $41.3 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $2.84 Million - $3.68 Million	-87,465 Reduced 7.69%	1,049,538 $37.7 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $4.83 Million - $5.42 Million	-130,629 Reduced 10.3%	1,137,003 $49.3 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $5.45 Million - $5.99 Million	-145,393 Reduced 10.29%	1,267,632 $53.8 Million
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $7.55 Million - $8.61 Million	-196,252 Reduced 12.2%	1,413,025 $61.7 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $1.11 Million - $1.35 Million	-32,310 Reduced 1.97%	1,609,277 $70.9 Million
Q2 2018 Aug 22, 2018	BUY	$32.98 - $35.16 $45.4 Million - $48.4 Million	1,376,035 Added 518.18%	1,641,587 $59.6 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $49.2 Million - $52.5 Million	-1,493,241 Reduced 84.9%	265,552 $59.6 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $566,881 - $657,660	-17,765 Reduced 1.0%	1,758,793 $63.9 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $1.36 Million - $1.45 Million	-40,990 Reduced 2.26%	1,776,558 $64.3 Million
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $56.3 Million - $62.1 Million	1,817,548	1,817,548 $64.9 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Pfizer Inc Transaction History